Navigation Links
Flavor and Function Are a Hot Match in 2009... Located In a Cool Place
Date:2/3/2009

Healthy, Balanced Living Made Easy and Delicious with New Yoplait Yo-Plus Blueberry Acai Yogurt with Live and Active Probiotic Cultures

MINNEAPOLIS, Feb. 3 /PRNewswire/ -- Probiotics, a hot food trend for 2009, joins forces with the latest flavor craze in the launch of Yoplait's new Yo-Plus Blueberry Acai [asa'i] yogurt with live and active probiotic cultures. According to a recent Yo-Plus survey*, nearly two-thirds of women are familiar with probiotics, a strong indication that this health trend continues to gain momentum as women become more aware of their options for healthy eating. Yoplait Yo-Plus contains live and active probiotic cultures and a natural fiber that promote digestive health. When eaten regularly, Yo-Plus can naturally regulate the balance of microorganisms in the digestive system.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090203/NE65738 )

"Make a year-round commitment to healthy, balanced living -- and start now! Yoplait's Yo-Plus can help," said Ellie Krieger, RD, New York Times best-selling author and celebrity chef. "Digestive health is an important part of our overall health and well-being, and Yo-Plus makes it easy to stay on track with an array of delicious flavors, including the new Blueberry Acai."

Yo-Plus also contains a natural dietary fiber, with three grams per 4-ounce serving, which provides digestive health benefits. The flavorful yogurt is a good source of calcium and vitamins A and D. In addition to the special probiotic culture Bifidobacterium Bb-12, Yo-Plus contains the live and active yogurt cultures L. bulgaricus and S. thermophilus.

"With the smooth texture and rich flavors -- like our new Blueberry Acai -- consumers can enjoy the health benefit of live and active cultures and fiber, as well as the great
'/>"/>

SOURCE General Mills
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Jenny Craig Announces Nationwide Voluntary Recall of Jennys Cuisine(R) Anytime Peanut Butter Flavor Nutritional Bars Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk
2. Flavoring Food May Promote Weight Loss
3. Whole Foods Markets(R) Destination Summer Celebrates a Journey of American Flavors; Kicks Off With Sweepstakes & Free Shopper Grilling Guide
4. Time for New Yorkers to Drink Low-Calorie, Low-Sugar Flavored Water, TrimWater
5. Fattening Foods May Have More Than Good Flavor in Their Corner
6. Flavor and Vitamins on the Go
7. Florida Orange Juice Adds a Healthy Splash of Flavor and Sunshine to Recipes
8. Latest Salvo Fired in Frozen Yogurt Wars as Southern Californias Fastest-Growing Franchise - Cefiore - Launches New Chocolate Flavor
9. FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good
10. Consumer demand flavors food import safety issues
11. Frutarom Acquires Gewurzmuller, a Company Specializing in Unique Savory Flavors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , Dr. Redlener Applauds Historic Effort b...et Programs Are Lost in Final Health Care Reform ... The New England Journal of Medicine today pub...th care reform, co-authored by Irwin Redlener, M.D... National Center for Disaster Preparedness and Pro...
(Date:12/4/2009)...with knowledge of risks, many hesitate to take bre... Dec. 4 (HealthDay News) -- Worries about side eff...ican women at high risk for breast cancer are will...ase, a new study finds. , In an effort to infor... researchers at the University of Michigan Compreh...
(Date:12/4/2009)... , BOULDER, Colo., Dec. 4 ..., ON LOVE ,, Kathryn Budig, a prominent yoga te...e to healing--with a viewing of Twilight,s New Moo...nal.com: ,, http://www.elephantjournal.com/200...ournal.com: TASHI KING AND BREAST CANCER ,, el...
(Date:12/4/2009)... , JEFFERSON CITY, Mo., Dec. 4 /PRNewswire/ ...ctor Paul Crosetti, State Fire Marshal Randy Cole,...en,s fire safety program sponsored by Farmers call... safety day at the Missouri Capitol December 9. .../20080605/LATH062 ) ,, "The call for fire safet...
(Date:12/4/2009)...le who have had an ischemic stroke are at higher l... of medication can reduce that risk. One of the si...s, otherwise known as blood thinners, of which the...tudy to determine whether the use of antithromboti...r a seven-year period found that in each of the ye...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Missouri Safety Day at the Capitol 2Health News:Are stroke survivors taking their medicine? 2
..., Dec. 3 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP...igational new,drug (IND) application to the U.S. F...und is an internally developed, orally-bioavailabl...r,patients in early 2008., "This IND submission i...
... N.Y., Dec. 3 Big A Drug Stores, Inc. has,selecte...al estate,solutions, to exclusively manage the dis...California. Big A Drug Stores, Inc. is a chain of ...gs,","Drug Fair," and "Drug Barn" (2 stores)., "W...
...APOLIS Although more and more drug advertisements...oximately $21 billion dollars that pharmaceutical ...is targeted to physicians, doctors in training (re...c. published in the December issue of the journal ...
...and PITTSBURGH, Dec. 2 Forest,Laboratories, Inc. ...ed that,Mylan has received an approvable letter fr...response to its New Drug Application (NDA) for,neb...icated that a recent inspection of,a backup manufa...
... communication with doctors and respect for role o...Y, Dec. 2 (HealthDay News) -- The death of a child...dparents, siblings, friends, even the child,s doct...ymptoms and stress of life-threatening illness -- ...
...ESTER, Ill. Hospital staff nurses who work extend...at work, or obtain less sleep are more likely to e... study published in the December 1 issue of the jo...ed from 895 full-time hospital staff nurses, who c...
Other Medicine News:Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3Health News:Big A Drug Stores, Inc. Retains DJM Realty to Dispose of All Stores Operating Under the Names of Drug Emporium, Big A, Camelot, Drug Fair and Drug Barn 2Health News:Do medical schools affect the way future doctors interact with drug companies? 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 3Health News:Breaking Down Barriers to End-of-Life Care for Children 2Health News:Breaking Down Barriers to End-of-Life Care for Children 3Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 2Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 3Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 4
(Date:12/4/2009)..., , BETHESDA, Md., Dec. 4 Dr...lts for prostate-specific antigen (PSA) recurrence...nts of biochemical recurrence rate in a Phase III ... for injection) or monthly leuprolide in prostate .... Prostate cancer patients who received FIRMAGON ...
(Date:12/3/2009)..., , NEW YORK, Dec. 3 Guid...rm, today announced the launch of their Sleep Apne...t monitors and projects trends and market share in...p Apnea Tracker captures actual patient usage for ...nited States from 15 different equipment providers...
(Date:12/3/2009)..., , SUNNYVALE, Calif., Dec. 3 /PRNewswire-..., a biopharmaceutical company focused on developin...ugs for the treatment of immune mediated diseases ...bcast and conference call on, Tuesday, December 8,...e and 8:00am Pacific Time) to discuss clinical dat...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 1Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 2Pearson Announces Leah Jewell as President of Health Science and Careers Division 55714 3ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 1ReBuilder Medical Technologies Inc s Dr Phillips to Speak to Ohio Investment Group 55711 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 1CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 2CriticalPoint 28TM 29 Launches Seven New Virtual Compounder 28TM 29 Training Modules 55708 3
...nc., a privately held biopharmaceutical company th...mmercialization of prescription ophthalmic pharmac... safety and efficacy results from the first human ...luocinolone acetonide (FA) intravitreal insert) wi...ion for Research in Vision and Ophthalmology (ARVO...
...President and Chief Executive Officer of Smithfiel...pdate to all employees on the progress of the test... in Veracruz: , , To Our Employees: , , The medi...outbreak on a minute-to-minute basis, and while we...ut the day-to-day status of the testing being cond...
Other Medicine Technology:Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting 2Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture 2
HOME MULTI-DRUG TEST
SEDIPLAST ESR SYSTEM (with diluent)
SEDIPLAST ESR SYSTEM (without diluent)
Hemaprompt FG Gastric and Fecal Occult Blood Test
Medicine Products: